OBJECTIVE: The aim of this study was to assess knowledge, beliefs, and practices of primary care clinicians regarding colorectal cancer screening. METHODS: We surveyed 77 primary care providers in six clinics in central Massachusetts to evaluate several factors related to colorectal cancer screening. RESULTS: Most agreed with guidelines for fecal occult blood test (97%) and sigmoidoscopy (87%), which were reported commonly as usual practice. Although the majority (86%) recommended colonoscopy as a colorectal cancer screening test, it was infrequently reported as usual practice. Also, 36% considered barium enema a colorectal cancer screening option, and it was rarely reported as usual practice. Despite lack of evidence supporting effectiveness, digital rectal examinations and in-office fecal occult blood test were commonly reported as usual practice. However, these were usually reported in combination with a guideline-endorsed testing option. Although only 10% reported that fecal occult blood test/home was frequently refused, 60% reported sigmoidoscopy was. Frequently cited patient barriers to sigmoidoscopy compliance included fear the procedure would hurt and that patients assume symptoms occur if there is a problem. Perceptions of health systems barriers to sigmoidoscopy were less strong. CONCLUSIONS: Most providers recommended guideline-endorsed colorectal cancer screening. However, patient refusal for sigmoidoscopy was common. Results indicate that multiple levels of intervention, including patient and provider education and systems strategies, may help increase prevalence.
OBJECTIVE: The aim of this study was to assess knowledge, beliefs, and practices of primary care clinicians regarding colorectal cancer screening. METHODS: We surveyed 77 primary care providers in six clinics in central Massachusetts to evaluate several factors related to colorectal cancer screening. RESULTS: Most agreed with guidelines for fecal occult blood test (97%) and sigmoidoscopy (87%), which were reported commonly as usual practice. Although the majority (86%) recommended colonoscopy as a colorectal cancer screening test, it was infrequently reported as usual practice. Also, 36% considered bariumenema a colorectal cancer screening option, and it was rarely reported as usual practice. Despite lack of evidence supporting effectiveness, digital rectal examinations and in-office fecal occult blood test were commonly reported as usual practice. However, these were usually reported in combination with a guideline-endorsed testing option. Although only 10% reported that fecal occult blood test/home was frequently refused, 60% reported sigmoidoscopy was. Frequently cited patient barriers to sigmoidoscopy compliance included fear the procedure would hurt and that patients assume symptoms occur if there is a problem. Perceptions of health systems barriers to sigmoidoscopy were less strong. CONCLUSIONS: Most providers recommended guideline-endorsed colorectal cancer screening. However, patient refusal for sigmoidoscopy was common. Results indicate that multiple levels of intervention, including patient and provider education and systems strategies, may help increase prevalence.
Authors: Maida J Sewitch; Pascal Burtin; Martin Dawes; Mark Yaffe; Linda Snell; Mark Roper; Patrizia Zanelli; Alan Pavilanis Journal: Can J Gastroenterol Date: 2006-11 Impact factor: 3.522
Authors: Christoph Heintze; Dorothea Matysiak-Klose; Thorsten Kröhn; Ute Wolf; Alexander Brand; Christoph Meisner; Imma Fischer; Hartwig Wehrmeyer; Vittoria Braun Journal: Br J Gen Pract Date: 2005-01 Impact factor: 5.386
Authors: Joshua J Fenton; Yong Cai; Noel S Weiss; Joann G Elmore; Roy E Pardee; Robert J Reid; Laura-Mae Baldwin Journal: Arch Intern Med Date: 2007-03-26
Authors: Nicholas J West; Christian Boustière; Wolfgang Fischbach; Fabrizio Parente; Roger J Leicester Journal: Int J Colorectal Dis Date: 2009-03-19 Impact factor: 2.571
Authors: Amy S Oxentenko; Nisheeth K Goel; Darrell S Pardi; Robert A Vierkant; Wesley O Petersen; Joseph C Kolars; Robert T Flinchbaugh; Timothy O Wilson; Katherine Sharpe; John H Bond; Robert A Smith; Bernard Levin; J Bart Pope; Paul C Schroy; Paul J Limburg Journal: J Cancer Educ Date: 2007 Impact factor: 2.037